Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Sun Pharmaceutical Inds.

Sector: Healthcare | Industry: Drugs & Pharma
R 414.70 -2.45  | -0.59% -33.08% 32.67 99,512.42
NSE Price: Aug 16, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Aug 16, 15:59 414.70 -2.45 -0.59% 419.40 417.15 6,536,156 410.00 - 421.40
BSE Aug 16, 2019 414.75 -2.30 -0.55% 419.85 417.05 312,082 410.10 - 424.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
TTM Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14
Income StatementR Cr
Operating Revenue30,216.1029,065.9126,415.5431,308.1428,108.61 27,392.0116,080.36
Other Income1,106.141,059.44912.081,030.20658.25 637.89592.59
Total Income31,322.2430,125.3527,327.6232,338.3428,766.86 28,029.9016,672.95
Total Expenditure23,586.9822,792.2720,880.7321,625.9219,950.29 19,615.549,120.95
Operating Profit7,735.267,333.086,446.8910,712.428,816.57 8,414.367,552.00
Interest528.41555.25517.57399.80523.24 578.9944.19
PBDT7,206.856,777.835,929.3210,312.628,293.33 7,835.377,507.81
Depreciation1,808.741,753.251,499.841,264.751,037.53 1,194.72409.23
PBT & Exceptional Items5,398.115,024.584,429.489,047.877,255.80 6,640.657,098.58
Exceptional Items-1,214.38-1,214.38-950.50--685.17 -237.75-2,517.41
Profit before Tax4,183.733,810.203,478.989,047.876,570.63 6,402.904,581.17
Provision for Tax607.08600.88911.041,211.57913.77 914.69702.17
Profit after Tax3,576.653,209.322,567.947,836.305,656.86 5,488.213,879.00
Minority Interest-523.05-542.44-446.80-881.86-1,112.60 -936.27-737.53
Share of Associate-7.20-1.46-25.449.931.45 -12.56-
Consolidated Profit3,046.392,665.422,095.706,964.374,545.71 4,539.383,141.47
 
LiabilitiesR Cr
Share Capital239.93239.93239.93239.93240.66 207.12207.12
Total Reserves41,169.1341,169.1338,074.1836,397.1032,736.26 25,374.3818,317.83
Shareholder's Funds41,409.0641,409.0638,314.1136,639.6732,982.48 25,638.0918,524.95
Minority Interest3,313.543,313.543,884.163,790.864,085.25 2,851.191,921.18
Long Term Borrowings1,522.611,522.611,772.091,436.083,110.30 1,368.4248.67
Other Non Current Liabilities1,108.981,004.70462.711,341.822,105.51 2,718.682,610.76
Current Liabilities17,339.6217,339.6219,864.3217,887.0213,143.96 16,146.815,989.59
Total Debt*-10,514.3610,385.279,831.778,496.76 8,996.112,560.86
Total Liabilities64,693.8164,589.5364,297.3961,095.4555,427.50 48,723.1929,095.15
 
AssetsR Cr
Net Block16,381.1321,836.5418,852.6517,675.1715,872.25 12,682.476,817.28
Non Current Investments3,951.813,951.813,052.25961.001,116.07 598.87787.56
Other Non-Current Assets13,291.687,731.9910,756.599,505.638,497.88 6,526.102,803.74
Current Investments3,950.723,950.724,090.62230.88713.81 2,117.431,998.46
Cash and Bank7,275.607,275.609,929.3815,140.8413,181.65 10,998.047,590.15
Other Current Assets19,842.8719,842.8717,615.9017,581.9316,045.84 15,800.289,097.85
Net Current Assets13,729.5713,729.5711,771.5815,066.6316,797.34 12,768.9412,696.87
Miscellaneous Exp. Not Written Off----- -0.11
Total Assets64,693.8164,589.5364,297.3961,095.4555,427.50 48,723.1929,095.15
 
Cash FlowR Cr
From Operations-2,196.453,907.157,082.216,685.86 5,615.743,959.20
From Investing Activities--681.25-3,370.81-4,221.60-4,371.59 -2,865.74-2,366.76
From Finance Activities--2,730.52-1,539.26-2,285.39-1,888.53 -1,186.53506.57
Net Inflow/Outflow--1,215.32-1,002.92575.22425.74 1,563.472,099.01
 
Key Ratios
Adjusted EPS (Rs)12.7011.118.7329.0318.89 21.9215.17
Adjusted Book Value (Rs)178.84172.59159.69152.70137.03 123.4989.44
Dividend per Share (Rs)-2.752.003.501.00 3.001.50
Cash Flow per Share (Rs)-9.1516.2829.5227.78 27.1119.12
Debt to Equity0.040.250.270.270.26 0.350.14
Current Ratio1.791.791.591.842.28 1.793.12
ROCE (%)-8.688.4021.4818.64 25.0625.46
RONW (%)9.008.056.8522.5119.32 24.8923.15
Operating Margin (%)25.6025.2324.4134.2231.37 30.7246.96
Net Margin (%)11.4210.659.4024.2319.66 19.5823.27
Revenue Growth (%)9.8610.03-15.6311.382.62 70.3442.31
Net Profit Growth (%)-13.3824.98-67.2338.533.07 41.4911.60
EPS Growth (%)-16.1627.19-69.9153.67-13.82 44.505.08
Book Value Growth (%)-8.084.5811.1028.93 38.0723.58
 
Market Cues
Close Price (Rs)414.70478.85495.10688.15820.00 1,023.90574.75
High Price (Rs)679.30679.30699.85854.951,200.80 1,075.00653.35
Low Price (Rs)344.55370.20432.70571.90704.00 570.10405.00
Market Cap (Rs Cr)99,512.42114,986.45118,861.32164,999.86197,208.84 211,728.42118,752.25
Price / Earnings32.6743.1456.7223.6943.38 46.6437.80
Price / Book Value2.322.783.104.505.98 8.286.41
Dividend Yield (%)0.660.570.400.510.12 0.290.26
TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
*Total Debt is long term borrowings plus short term borrowings plus current maturities of long term borrowings.
Essential checks
Altman Z-Score
4.86
Piotroski F-Score
8
Modified C-Score
2
5-Years Price to Earnings
32.67
5-Years Price to Book
2.32
Earnings Yield
EBIT / Enterprise value
4.77%
PEG
Price / Earnings to growth ratio
-2.84
Related Stocks
  Current Price   Chng %
Alkem Laboratories R1,761.85 -0.30%
Aurobindo Pharma R602.30 -0.53%
Biocon R228.00 -1.91%
Cadila Healthcare R217.75 -0.11%
Cipla R476.10 -0.46%
Divi's Laboratories R1,507.30 -1.61%
Dr. Reddy's Lab R2,492.55 -0.77%
Lupin R729.30 -0.68%
Piramal Enterprises R1,782.30 +0.95%
Torrent Pharmaceuticals R1,647.80 -2.27%
As on Aug 16, 15:59